The overexpression of OPN was observed in various human cancers and is associated with poor patient outcomes in a variety of cancers, such as breast cancer [15], lung cancer [16], liver cancer [17], gastric cancer [18], colon cancer [19], and cervical cancer [20]. This evidence concerns the gene SPP1 and gastric cancer.